( NASDAQ-SMALL:ETRM )

News from EnteroMedics Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 23, 2017, 08:30 ET EnteroMedics Announces Name Change to ReShape Lifesciences Inc. (NASDAQ: RSLS) $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that...


Oct 16, 2017, 08:00 ET EnteroMedics Announces Presentations at ObesityWeek 2017 $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Oct 12, 2017, 16:46 ET EnteroMedics Announces New Employee Inducement Option Grants $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Oct 03, 2017, 08:30 ET EnteroMedics Announces Acquisition Of ReShape Medical $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Sep 12, 2017, 08:30 ET EnteroMedics to Present at the Ladenburg Thalmann 2017 Healthcare Conference $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Sep 05, 2017, 16:15 ET EnteroMedics Begins Post-Approval Study for the Treatment of Obesity with vBloc Therapy $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Aug 28, 2017, 16:05 ET Study Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-Effective $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Aug 21, 2017, 09:00 ET EnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in Maryland $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), the developer of minimally invasive medical devices to treat obesity, metabolic diseases and other...


Aug 16, 2017, 09:00 ET EnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual Conference $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Aug 11, 2017, 08:20 ET EnteroMedics Announces Pricing of $20 Million Underwritten Public Offering $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Aug 10, 2017, 16:34 ET EnteroMedics Announces Proposed Underwritten Public Offering $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Aug 08, 2017, 07:00 ET EnteroMedics Announces Second Quarter 2017 Financial Results $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Aug 02, 2017, 07:00 ET EnteroMedics To Discuss Business Strategy And Financial Results For The Second Quarter Of 2017 $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Jul 31, 2017, 07:00 ET EnteroMedics Receives Approval for Gastric Vest System Clinical Study in Spain $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Jul 25, 2017, 07:00 ET EnteroMedics Announces First Veterans Choice Program vBloc® Implant for Obesity at Methodist Dallas Medical Center $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other...


Jul 20, 2017, 07:00 ET EnteroMedics Announces Receipt of European Patent Certificate $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal...


Jun 28, 2017, 07:00 ET EnteroMedics Announces Affordable vBloc® Therapy Program for Weight Loss Patients $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices to treat obesity, metabolic diseases, and other obesity-related comorbidities,...


Jun 26, 2017, 07:00 ET EnteroMedics Added to Russell Microcap® Index $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today...


Jun 21, 2017, 07:00 ET EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today...


May 31, 2017, 07:00 ET EnteroMedics Announces First vBloc® Neurometabolic Therapy Implant at AMITA Health Adventist Medical Center Bolingbrook $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, and...


May 23, 2017, 07:00 ET EnteroMedics Announces the Acquisition of the Gastric Vest System $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices treating obesity, metabolic diseases and other gastrointestinal disorders,...


May 18, 2017, 07:00 ET EnteroMedics Announces First vBloc® Neurometabolic Therapy Implant at McGuire Veterans Affairs Medical Center $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and...


May 16, 2017, 07:00 ET EnteroMedics Announces First Quarter 2017 Financial Results and Conference Call $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other...


May 11, 2017, 07:00 ET EnteroMedics to Host First Quarter 2017 Conference Call $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other...


Mar 13, 2017, 16:30 ET EnteroMedics' vBloc® Neurometabolic Therapy Featured on "The Doctors" TV Show $countyNameToPathMap.put("sp

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other...